Skip to main content
← All guides

Indiana vs Texas on USAspending: $3.8B vs $72.7B

Texas’s stacked USAspending.gov obligation stock is $72.7B; Indiana’s is $3.8B. Indiana files that smaller stock on 6,924,275 residents against Texas’s 31,290,831, which is why spending per capita is $80.53 versus $686.1. Award volume favors Texas, 530,634 against 58,316. FY2026 is $21.5B in Texas versus $557.6M in Indiana. The figures are obligations, not outlays.

Key figures

  • Texas $72.7B vs Indiana $3.8B in stacked USAspending obligations.
  • Per capita $686.1 vs $80.53 on 31,290,831 vs 6,924,275 residents.
  • Awards 530,634 vs 58,316; FY2026 $21.5B vs $557.6M.
  • Top industries: commercial building construction in Indiana; pharmaceutical preparation manufacturing in Texas.
  • Figures are USAspending.gov obligations, not Treasury outlays.

A $3.8B Midwest file with a cool $80.53 ratio

Texas’s $72.7B stacked stock sits well above Indiana’s $3.8B. Census population leans Texas: 31,290,831 versus 6,924,275. Intensity is the ranking that opens widest. $80.53 per capita in Indiana is far cooler than Texas’s $686.1. Cite those packet ratios beside the Census counts; they are not a second copy of $72.7B and $3.8B.

Award volume is thin on the Indiana side. 58,316 awards versus 530,634 is a much thinner action log. Row count is not average award size. Cite USAspending.gov. Do not invent a mean from 58,316 or 530,634.

Commercial building construction versus pharmaceutical preparation

Indiana’s lead NAICS is commercial and institutional building construction. Texas’s is pharmaceutical preparation manufacturing. A construction peak is a first read on Indiana’s $3.8B mix. A drug-manufacturing peak is a first read on Texas’s $72.7B mix. Buildings and pharmaceuticals are not the same label.

The 58,316 Indiana awards and 530,634 Texas awards include many actions outside those two industries. Use the Indiana and Texas state hubs for agencies and recipients. Both peaks are USAspending.gov obligation mixes. Outlays are not in the packet.

Indiana’s 58,316 awards and $557.6M FY2026 slice sit on 6,924,275 residents. Texas’s 530,634 awards and $21.5B sit on 31,290,831. Commercial and institutional building construction versus pharmaceutical preparation manufacturing remains the mix contrast on $3.8B and $72.7B. $80.53 versus $686.1 is the intensity ranking. Cite USAspending.gov.

FY2026: Indiana’s $557.6M versus Texas’s $21.5B

Fiscal year 2026 obligations are $557.6M in Indiana and $21.5B in Texas. Recency preserves Texas’s stacked dollar lead. Treat the year as a recency slice of obligations, not as Treasury cash already paid.

Do not divide $557.6M or $21.5B by 58,316 or 530,634 all-years awards. Spending per capita of $80.53 and $686.1 already sits beside Census counts of 6,924,275 and 31,290,831. Cite USAspending.gov for both cuts.

What $80.53 looks like on 6,924,275 residents

Indiana’s $3.8B on 6,924,275 people produces $80.53 per capita, much cooler than Texas’s $686.1 on 31,290,831. The construction peak sits on that cooler ratio and on 58,316 awards. The $557.6M FY2026 slice is the recency cut on the smaller stock.

Texas’s pharmaceutical peak, 530,634 awards, and $21.5B latest-year amount remain the larger file. Read a Midwest construction mix against a national-scale pharmaceutical file. Keep every dollar figure labeled as a USAspending.gov obligation.

How to read Indiana versus Texas

Read Texas first on stacked dollars ($72.7B vs $3.8B), population (31,290,831 vs 6,924,275), awards (530,634 vs 58,316), spending per capita ($686.1 vs $80.53), and FY2026 ($21.5B vs $557.6M). Note commercial and institutional building construction versus pharmaceutical preparation manufacturing.

The comparison hub holds the tables. The Indiana and Texas hubs hold agencies and recipients. Outlays are a different series. Cite USAspending.gov. Keep $80.53 and $686.1 labeled as Census-based obligation ratios.

A $80.53 Midwest construction ratio

Indiana’s commercial and institutional building construction peak sits on $3.8B, 6,924,275 residents, 58,316 awards, $80.53 per capita, and $557.6M in FY2026. Texas’s pharmaceutical preparation manufacturing peak sits on $72.7B, 31,290,831 residents, 530,634 awards, $686.1, and $21.5B. A sizable Midwest Census file still sits with a cool obligation ratio. Buildings and pharmaceuticals are not interchangeable labels.

Cite USAspending.gov. Keep $80.53 and $686.1 labeled as Census-based obligation ratios. Outlays are not in the packet. Use the comparison hub for tables. Use the Indiana and Texas hubs for agencies and recipients. Do not divide $3.8B or $72.7B by 58,316 or 530,634.

Questions

Does Indiana or Texas have more federal spending?
Texas leads stacked USAspending.gov obligations $72.7B to Indiana’s $3.8B, spending per capita $686.1 to $80.53, awards 530,634 to 58,316, and FY2026 obligations $21.5B to $557.6M. Population is 6,924,275 in Indiana and 31,290,831 in Texas.
What industries lead in Indiana and Texas?
Indiana’s top industry is commercial and institutional building construction. Texas’s is pharmaceutical preparation manufacturing. Those labels are the largest NAICS slices on $3.8B and $72.7B. Award counts are 58,316 in Indiana and 530,634 in Texas.
Why is Indiana’s per-capita figure so much lower?
The packet reports $80.53 per capita in Indiana on 6,924,275 residents and $686.1 in Texas on 31,290,831. Stacked stocks are $3.8B versus $72.7B. These figures are USAspending.gov obligations, not outlays. A sizable Census file can still sit with a cool ratio.
Are Indiana vs Texas figures Treasury outlays?
No. The $3.8B and $72.7B totals, and FY2026 amounts of $557.6M and $21.5B, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($80.53 vs $686.1) uses Census population where present. This packet does not publish outlays or average award size.

State comparison from SpendingVault aggregates of USAspending obligations. Per-capita uses Census population where present.